Myocarditis and inflammatory cardiomyopathy: from diagnosis to treatment [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 2015; 43(8): 739-748 | DOI: 10.5543/tkda.2015.47750

Myocarditis and inflammatory cardiomyopathy: from diagnosis to treatment

Felicitas Escher1, Carsten Tschoepe2, Dirk Lassner1, Heinz-Peter Schultheiss1
1Institute for Cardiac Diagnostics and Therapy (IKDT), Berlin, Germany
2Department of Cardiology, Campus Virchow Klinikum, Charite - Universitaetsmedizin Berlin, Berlin, Germany

Based on the definition in the European Society of Cardiology statement, myocarditis is an inflammatory disease of the myocardium diagnosed by established histological, immunological, and immunohistochemical criteria, whereas inflammatory cardiomyopathy is myocarditis in association with cardiac dysfunction. Actual incidences of myocarditis and CMi are difficult to determine. Studies addressing the issue of sudden cardiac death in young people report a highly variable autopsy prevalence of myocarditis, ranging from 2-42% of cases. Similarly, biopsy-proven myocarditis has been reported in 9-16% of adult patients with unexplained nonischemic dilated cardiomyopathy (DCM). In up to 30% of cases, biopsy-proven myocarditis can progress to DCM and is associated with a poor prognosis. Prognosis in myocarditis patients also varies according to underlying etiology.

Keywords: Inflammatory cardiomyopathy, myocarditis, myocardial diseases

How to cite this article
Felicitas Escher, Carsten Tschoepe, Dirk Lassner, Heinz-Peter Schultheiss. Myocarditis and inflammatory cardiomyopathy: from diagnosis to treatment. Turk Kardiyol Dern Ars. 2015; 43(8): 739-748

Corresponding Author: Felicitas Escher, Germany
© Copyright 2020 Archives of the Turkish Society of Cardiology
LookUs & Online Makale